Medplus Health Services Stock Current Valuation
| MEDPLUS Stock | 782.70 20.65 2.71% |
Valuation analysis of Medplus Health Services helps investors to measure Medplus Health's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. At this time, Medplus Health's Cash is comparatively stable compared to the past year. Cash And Short Term Investments is likely to gain to about 2.7 B in 2024, despite the fact that Total Cashflows From Investing Activities is likely to grow to (6 B). Fundamental drivers impacting Medplus Health's valuation include:
Price Book 5.4368 | Enterprise Value 98.6 B | Enterprise Value Ebitda 21.0855 | Price Sales 1.5852 | Forward PE 55.8659 |
Overvalued
Today
Please note that Medplus Health's price fluctuation is very steady at this time. Calculation of the real value of Medplus Health Services is based on 3 months time horizon. Increasing Medplus Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Medplus stock is determined by what a typical buyer is willing to pay for full or partial control of Medplus Health Services. Since Medplus Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Medplus Stock. However, Medplus Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 782.7 | Real 627.24 | Hype 782.7 | Naive 800.69 |
The intrinsic value of Medplus Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Medplus Health's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Medplus Health Services helps investors to forecast how Medplus stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Medplus Health more accurately as focusing exclusively on Medplus Health's fundamentals will not take into account other important factors: Medplus Health Services Company Current Valuation Analysis
Medplus Health's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Medplus Health Current Valuation | 98.61 B |
Most of Medplus Health's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medplus Health Services is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Medplus Health Services has a Current Valuation of 98.61 B. This is much higher than that of the Consumer Staples Distribution & Retail sector and significantly higher than that of the Consumer Staples industry. The current valuation for all India stocks is significantly lower than that of the firm.
Medplus Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medplus Health's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Medplus Health could also be used in its relative valuation, which is a method of valuing Medplus Health by comparing valuation metrics of similar companies.Medplus Health is currently under evaluation in current valuation category among its peers.
Medplus Fundamentals
| Return On Equity | 0.0428 | ||||
| Return On Asset | 0.028 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | 0.02 % | ||||
| Current Valuation | 98.61 B | ||||
| Shares Outstanding | 119.47 M | ||||
| Shares Owned By Insiders | 41.92 % | ||||
| Shares Owned By Institutions | 37.42 % | ||||
| Price To Book | 5.44 X | ||||
| Price To Sales | 1.59 X | ||||
| Revenue | 56.25 B | ||||
| Gross Profit | 9.82 B | ||||
| EBITDA | 3.94 B | ||||
| Net Income | 654.73 M | ||||
| Total Debt | 10.1 B | ||||
| Book Value Per Share | 132.00 X | ||||
| Cash Flow From Operations | 1.44 B | ||||
| Earnings Per Share | 8.31 X | ||||
| Target Price | 927.0 | ||||
| Number Of Employees | 23.41 K | ||||
| Beta | 0.77 | ||||
| Market Capitalization | 92.41 B | ||||
| Total Asset | 30.05 B | ||||
| Retained Earnings | 3.15 B | ||||
| Working Capital | 10.42 B | ||||
| Net Asset | 30.05 B |
About Medplus Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medplus Health Services's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medplus Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medplus Health Services based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Medplus Stock Analysis
When running Medplus Health's price analysis, check to measure Medplus Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medplus Health is operating at the current time. Most of Medplus Health's value examination focuses on studying past and present price action to predict the probability of Medplus Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medplus Health's price. Additionally, you may evaluate how the addition of Medplus Health to your portfolios can decrease your overall portfolio volatility.